Related Experiment Video
Updated: Jan 2, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis
1Department of Nephrology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, PR China.
Insights
High platelet-to-lymphocyte ratio (PLR) is a significant predictor of cardiovascular disease (CVD) events in continuous ambulatory peritoneal dialysis (CAPD) patients. This simple test can help identify patients at higher risk for CVD events.
Area of Science:
- Nephrology
- Cardiology
- Inflammation Biomarkers
Background:
- Patients with chronic kidney disease (CKD) exhibit elevated cardiovascular disease (CVD) risk, often linked to systemic inflammation.
- Platelet-to-lymphocyte ratio (PLR) is an emerging inflammatory marker.
- The inflammatory status in continuous ambulatory peritoneal dialysis (CAPD) patients is a key factor in CVD development.
Purpose of the Study:
- To investigate the association between PLR and the incidence of CVD events in CAPD patients.
- To determine if PLR can serve as a predictive marker for CVD events in this population.
Main Methods:
- A cohort of 70 stable CAPD patients was monitored from February 2014 to March 2017.
- Demographic and baseline clinical laboratory data were collected.
- Binary logistic regression analysis was employed to assess the relationship between PLR and CVD events.
Main Results:
- During a median follow-up of 22 months, 40% of CAPD patients experienced CVD events.
- Patients with CVD events showed significantly higher platelets, C-reactive protein, PLR, and neutrophil-to-lymphocyte ratio (NLR).
- High PLR was identified as an independent predictor of CVD events (OR, 1.05; 95% CI, 1.02-1.08; p<0.01), whereas high NLR was not.
Conclusions:
- PLR is independently associated with CVD events in CAPD patients.
- Elevated PLR can predict the risk of CVD events.
- PLR is an easily obtainable and potentially routine clinical test for risk assessment.
Background:
Chronic kidney disease (CKD) patients have a high incidence of cardiovascular disease (CVD) events, which is related to the inflammatory status of this population. Platelet-to-lymphocyte ratio (PLR) is a relatively new indicator of inflammation. The aim of this study was to investigate the relationship between PLR and the CVD events in continuous ambulatory peritoneal dialysis (CAPD) patients.
Methods:
A total of 70 stable CAPD patients were included in this study from February 2014 to March 2017, and complete demographic characteristics and clinical laboratory baseline data were collected at enrollment. The primary endpoint was defined as the experienced of CVD events during the follow-up period. Binary logistic regression was used to assess the association between PLR and CVD events in CAPD patients.
Results:
During a median follow-up period of 22 months, 28 (40%) CAPD patients experienced CVD events. Patients in the CVD event group had a high level of platelets (P < 0.01), C-reactive protein (P < 0.01), PLR (P < 0.01) and neutrophil-to-lymphocyte ratio (NLR) (P < 0.01). However, lymphocyte counts (P < 0.01) were significantly lower than patients without CVD events. Following adjusted binary regression analysis revealed no relationship between high NLR and CVD events (OR, 1.21; 95% CI, 0.52-2.85; p = 0.44). However, the correlation between high PLR and CVD events was significant (OR, 1.05; 95% CI, 1.02-1.08; p < 0.01). High PLR was confirmed as an independent predictor of CVD events.
Conclusion:
Our results demonstrated that PLR was independently associated with CVD events. High PLR can be used to predict the risk of CVD events in CAPD patients. PLR was easy to obtain and can be considered as a routine test to serve the clinic.
More Related Videos
07:11Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Continuous Renal Replacement Therapy
Peripheral Artery Disease I: Introduction